Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niklaus H Evitt

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The American Journal of Bioethics : AJOB|December 4, 2015
Human Germline CRISPR-Cas Modification: Toward a Regulatory FrameworkNiklaus H Evitt, Shamik Mascharak, Russ B Altman
The American Journal of Bioethics : AJOB|September 23, 2016
Response to Open Peer Commentaries on "Human Germline CRISPR-Cas Modification: Toward a Regulatory Framework"Niklaus H Evitt, Shamik Mascharak, Russ B Altman
Circulation|February 28, 2018
Reduced Blood Lipid Levels With In Vivo CRISPR-Cas9 Base Editing of ANGPTL3Alexandra C Chadwick, Niklaus H Evitt, Wenjian Lv, et al.
Journal of Biological Engineering|June 26, 2015
Chemical lysis of cyanobacteriaKunal K Mehta, Niklaus H Evitt, James R Swartz
Angewandte Chemie (International Ed. in English)|December 16, 2016
High-Throughput Screening of Catalytic H<sub>2</sub> ProductionJamin Koo, Tim Schnabel, Sylvie Liong, et al.
Nature Communications|July 15, 2020
High-performance CRISPR-Cas12a genome editing for combinatorial genetic screeningRodrigo A Gier, Krista A Budinich, Niklaus H Evitt, et al.
Nucleic Acids Research|January 23, 2024
Cooperativity between Cas9 and hyperactive AID establishes broad and diversifying mutational footprints in base editorsKiara N Berríos, Aleksia Barka, Jasleen Gill, et al.
Nature Chemical Biology|October 19, 2021
Controllable genome editing with split-engineered base editorsKiara N Berríos, Niklaus H Evitt, Rachel A DeWeerd, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The American Journal of Bioethics : AJOB|December 4, 2015
Human Germline CRISPR-Cas Modification: Toward a Regulatory FrameworkNiklaus H Evitt, Shamik Mascharak, Russ B Altman
The American Journal of Bioethics : AJOB|September 23, 2016
Response to Open Peer Commentaries on "Human Germline CRISPR-Cas Modification: Toward a Regulatory Framework"Niklaus H Evitt, Shamik Mascharak, Russ B Altman
Circulation|February 28, 2018
Reduced Blood Lipid Levels With In Vivo CRISPR-Cas9 Base Editing of ANGPTL3Alexandra C Chadwick, Niklaus H Evitt, Wenjian Lv, et al.
Journal of Biological Engineering|June 26, 2015
Chemical lysis of cyanobacteriaKunal K Mehta, Niklaus H Evitt, James R Swartz
Angewandte Chemie (International Ed. in English)|December 16, 2016
High-Throughput Screening of Catalytic H<sub>2</sub> ProductionJamin Koo, Tim Schnabel, Sylvie Liong, et al.
Nature Communications|July 15, 2020
High-performance CRISPR-Cas12a genome editing for combinatorial genetic screeningRodrigo A Gier, Krista A Budinich, Niklaus H Evitt, et al.
Nucleic Acids Research|January 23, 2024
Cooperativity between Cas9 and hyperactive AID establishes broad and diversifying mutational footprints in base editorsKiara N Berríos, Aleksia Barka, Jasleen Gill, et al.
Nature Chemical Biology|October 19, 2021
Controllable genome editing with split-engineered base editorsKiara N Berríos, Niklaus H Evitt, Rachel A DeWeerd, et al.
Pageof 1